US 7141553
A3AR agonists for the treatment of inflammatory arthritis
granted A61KA61K31/7076A61P
Quick answer
US patent 7141553 (A3AR agonists for the treatment of inflammatory arthritis) held by Can-Fite Biopharma Ltd. Israel expires Mon Nov 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Can-Fite Biopharma Ltd. Israel
- Grant date
- Tue Nov 28 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K31/7076, A61P, A61P19/02